2009-11-10 02:10:04 -

Vivakor, Inc. (OTCBB: VIVK) today announced it has completed a pilot product evaluation program with consumer product specialist, Regeneca International, Inc. ( www.regeneca.com : ).

The product evaluation involved Vivakor’s proprietary nutraceutical formulation derived from natural sources. Research has shown that phytochemicals, vitamins, minerals, and fiber, all present in fruits and vegetables, work synergistically to promote health and lower disease risk. For this reason, many organizations, such as the National Cancer Institute and The American Heart Association, recommend getting phytochemicals from whole foods, such as fruits and vegetables. The Vivakor product is a whole food supplement designed to deliver these essential nutrients to the users in small, single dose units.

Regeneca’s President, Larry Walter gave his thoughts on the study.

“Not only are the consumer study results impressive, but the overall opportunity to work with the team of professionals at Vivakor gives us a great deal of optimism for our future dealings with the company.”


The parties plan additional studies with the hope of a market ready product by early 2010.



About Vivakor, Inc.

Vivakor™ is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds, that extend or improve life. More information can be found about Vivakor at www.vivakor.com : .


FORWARD-LOOKING STATEMENTS

This press release may contain forward-looking statements, including, but not limited to, statements regarding Vivakor’s nutraceutical products and their related market potential. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor’s filings with the Securities and Exchange Commission, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. Vivakor undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes.



Vivakor, Inc.Matt Nicosia, 319-625-2172 mnicosia@vivakor.com : mailto:mnicosia@vivakor.com